Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Hepatology. 2016 Jul 17;64(6):1969–1977. doi: 10.1002/hep.28677

Table 3.

Distribution of Chronic Liver Disease and Cirrhosis by Etiologies and Race/Ethnicity in the Multiethnic Cohort, 1999–2012

CLD without cirrhosis HBV
n=98
HCV
n=190
ALD
n=591
NAFLD
n=2,344
Others
n=191
Cryptogenic
n=161
All Cases
n=3,575

White 15 (2.3%) 38 (5.9%) 151 (23.6%) 357 (55.8%) 41 (6.4%) 38 (5.9%) 640
African American 11 (3.6%) 39 (12.8%)** 82 (27.0%) 150 (49.3%)** 8 (2.6%)** 14 (4.6%) 304
Native Hawaiian 2 (1.0%) 5 (2.6%) 34 (17.6%) 140 (72.5%)* 7 (3.6%) 5 (2.6%) 193
Japanese American 50 (2.8%) 56 (3.2%)** 183 (10.4%)* 1,283 (72.9%)* 100 (5.7%) 88 (5.0%) 1,760
Latino 20 (2.9%) 52 (7.7%) 141 (20.8%) 414 (61.1%) 35 (5.2%) 16 (2.4%)** 678

Cirrhosis HBV
n=82
HCV
n=476
ALD
n=604
NAFLD
n=646
Others
n=185
Cryptogenic
n=215
All Cases
n=2,208

White 16 (3.1%) 84 (16.5%) 194 (38.2%) 110 (21.7%) 39 (7.7%) 65 (12.8%) 508
African American 8 (2.6%) 91 (29.8%)* 78 (25.6%)** 89 (29.2%)** 15 (4.9 %) 24 (7.9%)** 305
Native Hawaiian 7 (6.5%) 5 (4.6%)** 33 (30.6%) 34 (31.5%)** 14 (13.0 %) 15 (13.9%) 108
Japanese American 29 (5.5%) 98 (18.7%) 93 (17.8%)* 169 (32.3%)** 71 (13.6%)** 63 (12.0%) 523
Latino 22 (2.9%) 198 (25.9%)* 206 (27.0%)* 244 (31.9%)* 46 (6.0%) 48 (6.3%)* 764

HCV cases with HBV were also included in this group.

*

P≤0.0001 compared with Whites and adjusted for sex and duration of Medicare enrollment.

**

P<0.05 compared with Whites and adjusted for sex and duration of Medicare enrollment.